Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2613-2624
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2613
Table 5 Coagulation factors and platelet activity test with regards to the severity of cirrhosis, as evaluated according to the model of end-stage liver disease score
All patients (n = 51)MELD ≤ 18 (n = 28)MELD > 18 (n = 23)
Thrombosis17/51 (33%)11/28 (39.2%)7/23 (30.4%)
PT (s)13.8 (11.3-44)14.1 (11.3-21)19.1 (13.4.-44)1
Prothrombin activity (%)67 (36-106)76.4 (43-106)55.6 (36-86)1
INR1.3 (1-2.2)1.3 (1-1.5)1.6 (1.2-2.2)1
APTT34.7 (23.6-57)35.1 (23.6-57)34.4 (28.2-44.9)
TRAP test49.6 (12-156)56.2 (15-156)42.1 (12-113)1
ASPI test36.8 (5-130)45.9 (10-130)26.4 (5-108)1
ADP test31.6 (1-99.9)36.2 (7-99.9)26.5 (1-94)
RISTO low test10.9 (0-35)10.6 (1-25)11.3 (0-35)
RISTO high test56.5 (4-162)68.5 (7-156)43 (4-162)1
D-dimer (mg/L)3568 (563-11026)3094 (563-9455)4144 (724-11026)
Protein C (%)56.5 (20.9-177.5)58.7 (20.9-105.1)66.7 (29.4-177.5)
Prothrombin (μg/mL)136.8 (36-422)143.6 (36-390)128.5 (59-422)
vWf (mU/mL)1941 (981-2372)1841 (986-2372)2006 (981-2311)1
vWf (IU/mL)3.8 (1-7.7)3.7 (1.5-7.6)4.2 (1-7.7)
Omentin (ng/mL)1023 (579-2208)948 (579-1432)1110 (619-2208)
Vaspin (ng/mL)0.29 (0.1-0.8)0.25 (0.1-0.8)0.32 (0.1-0.8)